Skip to main content

Market Overview

Thoratec Could Fetch $65-$70 In Buyout, Predicts Northland's Suraj Kalia

Share:

In a report published Wednesday, Northland Capital Markets analyst Suraj Kalia maintained an Outperform rating on Thoratec Corporation (NASDAQ: THOR), with a price target of $55, amid speculations of the company being acquired by St. Jude Medical, Inc. (NYSE: STJ).

Bloomberg had reported of a possible THOR acquisition, with St. Jude Medical being the rumored buyer. Analyst Suraj Kalia believes that if such an acquisition does take place, it would value Thoratec at $65-$70 per share. This translates into a takeout value of about $3.5B.

"While this would represent approx 7x FY16 sales, we believe it does not factor in the significant potential from THOR's entry into the acute HF space, the share gains from launch of HM-III, and finally, any behind the curtain work being done on ECMO platforms," Kalia wrote.

In the report Northland Capital Markets noted that although Thoratec had "lost ground" in the VAD wars, the company's new CEO Keith Grossman seemed to have "shepherded the company well."

Kalia added that while the TET systems appear to be 3 years away, "St. Jude's CardioMems HF monitoring device combined with VAD therapy "could" allow for better patient management, reduced HF-related hospitalizations, and overall cost management."

Latest Ratings for THOR

DateFirmActionFromTo
Dec 2019JefferiesDowngradesBuyHold
Dec 2019SVB LeerinkDowngradesOutperformMarket Perform
Dec 2019Evercore ISI GroupDowngradesOutperformIn-Line

View More Analyst Ratings for THOR
View the Latest Analyst Ratings

 

Related Articles (THOR + STJ)

View Comments and Join the Discussion!

Posted-In: Northland Capital marketsAnalyst Color Reiteration Analyst Ratings

Latest Ratings

StockFirmActionPT
SVLake StreetInitiates Coverage On20.0
CLSDJMP SecuritiesMaintains9.0
WPCJP MorganUpgrades88.0
BRKRCleveland ResearchUpgrades
NTRRaymond JamesDowngrades82.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com